RGNX Operating Cash Flow Growth
Regenxbio Inc · Operating Cash Flow Growth
RGNX Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported-180.67%period ending
RGNX TTM Cash from Operations YoY % (-838.52% → -180.67%)
Year-over-year change
High-resolution chart · PNG
RGNX operating cash flow growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow Growth |
|---|---|
| -180.675% | |
| -178.1714% | |
| 28.3968% | |
| 43.3247% | |
| 54.015% | |
| 56.4428% | |
| 20.7329% | |
| 16.0161% | |
| 12.3581% | |
| 17.0115% | |
| -5.2625% | |
| -237.2487% | |
| -231.3077% | |
| -217.4508% | |
| -198.8909% | |
| 305.4747% | |
| 334.2006% | |
| 416.5443% | |
| 488.1079% | |
| 35.3518% | |
| 36.5325% | |
| 45.1356% | |
| 49.8064% | |
| -37.8693% | |
| -45.5872% | |
| -762.0259% | |
| -202.9212% | |
| -190.9195% | |
| -178.8053% | |
| -2.3038% | |
| 280.4525% | |
| 247.025% | |
| 264.3013% | |
| 130.3051% | |
| -19.4283% | |
| -98.2596% | |
| -103.2962% | |
| -102.4298% | |
| -115.6696% | |
| -81.655% | |
| -122.6762% | |
| -443.3516% | |
| -838.516% |